Clinical Trials in Michigan

Showing 4621-4640 of 11,164 trials

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

NCT04294004

The purpose of this study is to evaluate the safety and efficacy of KUR-113 Bone Graft (TGplPTH1-34 in fibrin) compared to local autograft for the treatment of Degenerative Disk Disease (DDD).

Degenerative Disc DiseaseSpinal Fusion

Kuros Biosurgery AG50 participantsStarted Aug 2020

La Jolla, California, United States • Boulder, Colorado, United States • Washington D.C., District of Columbia, United States +12 more locations

TERMINATED91 miles

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

NCT05266430

This is a prospective multicenter, group-matched study of patients with primary indeterminate lesions or choroidal melanoma who receive treatment with belzupacap sarotalocan (bel-sar; AU-011) and patients who are planned to receive standard of care (SOC) treatment with plaque radiotherapy (plaque) to compare the visual outcomes of AU-011 and plaque radiotherapy.

Choroidal MelanomaIndeterminate Lesions

Aura Biosciences2 participantsStarted Apr 2022

Royal Oak, Michigan, United States • Portland, Oregon, United States • Greenville, South Carolina, United States +4 more locations

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Find Trials by Condition in Michigan

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

Bortezomib in Treating Patients With Mantle Cell Lymphoma

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

A Phase I Study of CX5461

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma